MMWR Morb Mortal Wkly Rep. 2013 Mar 8;62(9):165-70.
Enterobacteriaceae are a family of bacteria that commonly cause infections in health-care settings as well as in the community. Among Enterobacteriaceae, resistance to broad-spectrum carbapenem antimicrobials has been uncommon. Over the past decade, however, carbapenem-resistant Enterobacteriaceae (CRE) have been recognized in health-care settings as a cause of difficult-to-treat infections associated with high mortality.
The percentage of acute-care hospitals reporting at least one CRE from health-care-associated infections (HAIs) in 2012 was estimated using data submitted to the National Healthcare Safety Network (NHSN) in 2012. The proportion of Enterobacteriaceae infections that were CRE was calculated using two surveillance systems: 1) the National Nosocomial Infection Surveillance system (NNIS) and NHSN (for 2001 and 2011, respectively) and 2) the Surveillance Network-USA (TSN) (for 2001 and 2010). Characteristics of CRE culture-positive episodes were determined using data collected as part of a population-based CRE surveillance project conducted by the Emerging Infections Program (EIP) in three states.
In 2012, 4.6% of acute-care hospitals reported at least one CRE HAI (short-stay hospitals, 3.9%; long-term acute-care hospitals, 17.8%). The proportion of Enterobacteriaceae that were CRE increased from 1.2% in 2001 to 4.2% in 2011 in NNIS/NHSN and from 0% in 2001 to 1.4% in 2010 in TSN; most of the increase was observed in Klebsiella species (from 1.6% to 10.4% in NNIS/NHSN). In the EIP surveillance, 92% of CRE episodes occurred in patients with substantial health-care exposures.
Carbapenem resistance among common Enterobacteriaceae has increased over the past decade; most CRE are associated with health-care exposures.
Interventions exist that could slow the dissemination of CRE. Health departments are well positioned to play a leading role in prevention efforts by assisting with surveillance, situational awareness, and coordinating prevention efforts.
肠杆菌科是一类常见的细菌,它们在医疗机构和社区中常引起感染。在肠杆菌科中,对广谱碳青霉烯类抗菌药物的耐药性并不常见。然而,在过去十年中,医疗机构中的耐碳青霉烯肠杆菌科(CRE)已被认为是导致难以治疗的感染的原因之一,这些感染与高死亡率相关。
使用 2012 年向国家医疗保健安全网络(NHSN)提交的数据,估计 2012 年报告至少有一种耐碳青霉烯类抗菌药物的肠杆菌科细菌引起的与医疗保健相关感染(HAI)的急症医院比例。使用两个监测系统计算肠杆菌科感染中耐碳青霉烯类抗菌药物的比例:1)国家医院感染监测系统(NNIS)和 NHSN(分别为 2001 年和 2011 年)和 2)监测网络-美国(TSN)(分别为 2001 年和 2010 年)。通过在三个州开展的新兴感染项目(EIP)进行的基于人群的耐碳青霉烯类肠杆菌科细菌监测项目收集的数据,确定耐碳青霉烯类肠杆菌科细菌培养阳性病例的特征。
2012 年,4.6%的急症医院报告至少有一种耐碳青霉烯类抗菌药物的肠杆菌科细菌引起的 HAI(短期住院医院,3.9%;长期急性护理医院,17.8%)。NNIS/NHSN 中肠杆菌科对碳青霉烯类的耐药率从 2001 年的 1.2%增加到 2011 年的 4.2%,而 TSN 中从 2001 年的 0%增加到 2010 年的 1.4%;这种增加主要发生在克雷伯氏菌属(NNIS/NHSN 中从 1.6%增加到 10.4%)。在 EIP 监测中,92%的耐碳青霉烯类肠杆菌科细菌感染发生在有大量卫生保健暴露的患者中。
在过去十年中,常见肠杆菌科对碳青霉烯类的耐药性有所增加;大多数耐碳青霉烯类肠杆菌科细菌与卫生保健暴露有关。
存在可以减缓耐碳青霉烯类肠杆菌科细菌传播的干预措施。卫生部门在通过协助监测、了解情况和协调预防工作来发挥领导作用方面具有优势。